⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11411907 | 0.97 | — | — | |
| SCHEMBL8352247 | 0.79 | LDHA (0.50) | — | |
| Sarcosine SCHEMBL20608183 | 0.78 | — | — | |
| SCHEMBL13034177 | 0.75 | — | — | |
| Sarcosine SCHEMBL156329 | 0.73 | LDHA (0.44) | — | |
| Sarcosine SCHEMBL31427574 | 0.73 | — | — | |
| Sarcosine SCHEMBL149 | 0.73 | — | — | |
| Sarcosine SCHEMBL28259932 | 0.73 | — | — | |
| Sarcosine SCHEMBL26641423 | 0.73 | LDHA (0.44) | — | |
| SCHEMBL9509093 | 0.73 | LDHA (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 593 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105785030-A | Light-activating chemiluminescence immunoassay kit for serum specific IgE (immunoglobulin E) | 博阳生物科技（上海）有限公司 | 2016-07-20 | — | — | CN | claimed |
| US-8980843-B2 | Leptin agonist and methods of use | Temple University—Of the Commonwealth System of Higher Education (US) | 2015-03-17 | — | — | US | claimed |
| CN-102798725-A | Diagnostic kit for determination of serum total IgE, preparation method and application method | WATSON & CRICK TIANJIN BIOTECHNOLOGY CO LTD | 2012-11-28 | — | — | CN | claimed |
| CN-102735833-A | Thyroperoxidase antibody homogeneous-phase luminescent immunoassay kit and detection method thereof | WATSON & CRICK TIANJIN BIOTECHNOLOGY CO LTD | 2012-10-17 | — | — | CN | claimed |
| CN-102721813-A | Homogeneous luminous immunoassay assay kit for prostate specific antigen and detection method therefor | WATSON & CRICK TIANJIN BIOTECHNOLOGY CO LTD | 2012-10-10 | — | — | CN | claimed |
| US-20260146293-A1 | METHODS OF DETECTING PROSTATE CANCER | IMMUNIS.AI, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| EP-4746895-A1 | A PEPTIDE COMPOSITION AND USES THEREOF | OPTM.RX Ltd (IL) | 2026-05-27 | — | — | EP | disclosed |
| EP-4689188-A2 | ACTIVE SURVEILLANCE AND RISK STRATIFICATION FOR PROSTATE CANCER | Immunis.AI, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4687986-A1 | PEPTIDE TRANS-MEMBRANE DELIVERY SYSTEMS AND USES THEREOF | Interna Therapeutics Ltd. (IL) | 2026-02-11 | — | — | EP | disclosed |
| US-20260021158-A1 | GRANULAR COMPOSITIONS COMPRISING A PEPTIDE AND USES THEREOF | Tarsier Pharma Ltd (IL) | 2026-01-22 | — | — | US | disclosed |
| US-12529109-B2 | Methods of detecting prostate cancer | IMMUNIS.AI, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20250346939-A1 | Method of Making Proteins with Non-Standard Amino Acids | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-11-13 | — | — | US | disclosed |
| WO-1996000708-A1 | METHOD FOR PREPARING ALKYLATING AGENTS AND THEIR USE FOR ALKYLATING CYCLIC UREAS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-01-11 | — | — | WO | disclosed |
| WO-1996000728-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF CYCLIC UREA HIV PROTEASE INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-01-11 | — | — | WO | disclosed |
| EP-0686151-A1 | SUBSTITUTED CYCLIC CARBONYLS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-12-13 | — | — | EP | disclosed |
| US-5466797-A | Intermediates for the preparation of cyclic urea | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-11-14 | — | — | US | disclosed |
| WO-1995029892-A1 | HYDROXAMIC ACID AND AMINO ACID DERIVATIVES AND THEIR USE AS ANTI-ARTHRITIC AGENTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-11-09 | — | — | WO | disclosed |
| WO-1995010506-A1 | 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-04-20 | — | — | WO | disclosed |
| WO-1994022840-A1 | SUBSTITUTED CAPROLACTAMS AND DERIVATIVES THEREOF USEFUL FOR TREATMENT OF HIV DISEASE | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-10-13 | — | — | WO | disclosed |
| WO-1994019329-A1 | SUBSTITUTED CYCLIC CARBONYLS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-09-01 | — | — | WO | disclosed |